156 related articles for article (PubMed ID: 24842749)
1. Inverse correlation of carotid intima-media thickness with raloxifene serum levels in osteoporosis.
Lušin TT; Mrhar A; Marc J; Trontelj J; Zavratnik A; Zegura B; Pfeifer M; Ostanek B
Wien Klin Wochenschr; 2014 Jul; 126(13-14):403-8. PubMed ID: 24842749
[TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
[TBL] [Abstract][Full Text] [Related]
3. Carotid artery intima-media thickness after raloxifene treatment.
Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene slows down the progression of intima-media thickness in postmenopausal women.
Colacurci N; Fornaro F; Cobellis L; De Franciscis P; Torella M; Sepe E; Arciello A; Cacciapuoti F; Paolisso G; Manzella D
Menopause; 2007; 14(5):879-84. PubMed ID: 17667145
[TBL] [Abstract][Full Text] [Related]
5. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
Hypertens Res; 2005 Jul; 28(7):579-84. PubMed ID: 16335886
[TBL] [Abstract][Full Text] [Related]
6. Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents.
Głowińska-Olszewska B; Tołwińska J; Urban M
J Pediatr Endocrinol Metab; 2007 Oct; 20(10):1125-36. PubMed ID: 18051931
[TBL] [Abstract][Full Text] [Related]
7. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
[TBL] [Abstract][Full Text] [Related]
8. [Interrelationship between endothelial dysfunction, IMT of the carotid arteries and adhesion molecules in obese hypertensive children and adolescents].
Głowińska-Olszewska B; Tołwińska J; Urban M
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):7-14. PubMed ID: 17493400
[TBL] [Abstract][Full Text] [Related]
9. Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.
Mosca L; Harper K; Sarkar S; O'Gorman J; Anderson PW; Cox DA; Barrett-Connor E
Clin Ther; 2001 Sep; 23(9):1552-65. PubMed ID: 11589267
[TBL] [Abstract][Full Text] [Related]
10. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
Cranney A; Adachi JD
Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
[TBL] [Abstract][Full Text] [Related]
11. p53 Levels positively correlate with carotid intima-media thickness in patients with subclinical atherosclerosis.
Chen W; Wang F; Li Z; Huang X; Wang N; Dong Z; Sun P
Clin Cardiol; 2009 Dec; 32(12):705-10. PubMed ID: 20027663
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene: a review of its use in the prevention of invasive breast cancer.
Moen MD; Keating GM
Drugs; 2008; 68(14):2059-83. PubMed ID: 18778124
[TBL] [Abstract][Full Text] [Related]
14. Should we consider gestational diabetes a vascular risk factor?
Bo S; Valpreda S; Menato G; Bardelli C; Botto C; Gambino R; Rabbia C; Durazzo M; Cassader M; Massobrio M; Pagano G
Atherosclerosis; 2007 Oct; 194(2):e72-9. PubMed ID: 17055515
[TBL] [Abstract][Full Text] [Related]
15. Review on raloxifene: profile of a selective estrogen receptor modulator.
Heringa M
Int J Clin Pharmacol Ther; 2003 Aug; 41(8):331-45. PubMed ID: 12940590
[TBL] [Abstract][Full Text] [Related]
16. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.
Papagianni A; Kalovoulos M; Kirmizis D; Vainas A; Belechri AM; Alexopoulos E; Memmos D
Nephrol Dial Transplant; 2003 Jan; 18(1):113-9. PubMed ID: 12480968
[TBL] [Abstract][Full Text] [Related]
17. Review of raloxifene and its clinical applications in osteoporosis.
Maricic M; Gluck O
Expert Opin Pharmacother; 2002 Jun; 3(6):767-75. PubMed ID: 12036416
[TBL] [Abstract][Full Text] [Related]
18. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).
Thakore AH; Guo CY; Larson MG; Corey D; Wang TJ; Vasan RS; D'Agostino RB; Lipinska I; Keaney JF; Benjamin EJ; O'Donnell CJ
Am J Cardiol; 2007 Jun; 99(11):1598-602. PubMed ID: 17531588
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial.
Morii H; Ohashi Y; Taketani Y; Fukunaga M; Nakamura T; Itabashi A; Sarkar S; Harper K
Osteoporos Int; 2003 Oct; 14(10):793-800. PubMed ID: 12955333
[TBL] [Abstract][Full Text] [Related]
20. [Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].
Głowińska-Olszewska B; Urban M; Tołwińska J; Peczyńska J; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):221-7. PubMed ID: 16232360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
